Bio-Rad Laboratories PE Ratio 2006-2021 | BIO.B

Current and historical p/e ratio for Bio-Rad Laboratories (BIO.B) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bio-Rad Laboratories PE ratio as of October 26, 2021 is 46.31.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Bio-Rad Laboratories PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-10-27 729.86 5.44
2021-06-30 640.00 $134.15 4.77
2021-03-31 579.38 $135.98 4.26
2020-12-31 574.15 $126.32 4.55
2020-09-30 508.00 $116.82 4.35
2020-06-30 436.97 $64.50 6.77
2020-03-31 351.32 $52.21 6.73
2019-12-31 369.60 $58.23 6.35
2019-09-30 340.54 $12.04 28.28
2019-06-30 306.18 $29.61 10.34
2019-03-31 303.00 $18.62 16.27
2018-12-31 230.00 $11.65 19.74
2018-09-30 297.67 $41.85 7.11
2018-06-30 285.75 $33.87 8.44
2018-03-31 250.90 $25.17 9.97
2017-12-31 238.25 $3.81 62.53
2017-09-30 228.01 $0.79 288.62
2017-06-30 225.00 $0.50 450.00
2017-03-31 199.80 $0.94 212.55
2016-12-31 183.15 $0.95 192.79
2016-09-30 162.52 $3.33 48.80
2016-06-30 141.99 $3.30 43.03
2016-03-31 135.03 $3.66 36.89
2015-12-31 137.68 $3.85 35.76
2015-09-30 132.79 $3.51 37.83
2015-06-30 146.50 $3.31 44.26
2015-03-31 135.00 $3.43 39.36
2014-12-31 120.51 $3.05 39.51
2014-09-30 115.55 $2.75 42.02
2014-06-30 123.45 $2.11 58.51
2014-03-31 127.95 $2.22 57.64
2013-12-31 123.71 $2.67 46.33
2013-09-30 118.00 $3.28 35.98
2013-06-30 113.00 $5.01 22.55
2013-03-31 122.25 $5.50 22.23
2012-12-31 104.08 $5.91 17.61
2012-09-30 108.61 $6.34 17.13
2012-06-30 100.33 $6.47 15.51
2012-03-31 103.42 $6.19 16.71
2011-12-31 95.31 $6.26 15.23
2011-09-30 90.10 $6.59 13.67
2011-06-30 117.87 $6.57 17.94
2011-03-31 118.57 $6.51 18.21
2010-12-31 104.57 $6.59 15.87
2010-09-30 91.05 $5.53 16.46
2010-06-30 87.25 $5.32 16.40
2010-03-31 103.14 $5.34 19.31
2009-12-31 97.86 $5.20 18.82
2009-09-30 91.66 $3.55 25.82
2009-06-30 76.77 $3.18 24.14
2009-03-31 65.18 $3.39 19.23
2008-12-31 69.71 $3.25 21.45
2008-09-30 101.52 $4.00 25.38
2008-06-30 81.66 $4.02 20.31
2008-03-31 89.45 $3.39 26.39
2007-12-31 105.02 $3.42 30.71
2007-09-30 90.67 $3.58 25.33
2007-06-30 75.00 $3.41 21.99
2007-03-31 70.00 $3.66 19.13
2006-12-31 83.40 $3.83 21.78
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $21.730B $2.546B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86